SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-214095
Filing Date
2017-06-27
Accepted
2017-06-27 08:36:02
Documents
3
Effectiveness Date
2017-06-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d419294ddefa14a.htm DEFA14A 33358
2 GRAPHIC g419294g20g21.jpg GRAPHIC 7396
3 GRAPHIC g419294g20r89.jpg GRAPHIC 7876
  Complete submission text file 0001193125-17-214095.txt   55759
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 17931195
SIC: 2834 Pharmaceutical Preparations